StockDuty ← Dashboard Sep 10, 2026 01:36 PM ET
CatalystCorporate

OPUS GENETICS, INC. (IRD) DISCUSSES TOPLINE RESULTS FROM COHORT 1 OF BEST1 PHASE I/II GENE THERAPY TRIAL TRANSCRIPT - SEEKINGALPHA

High-priority alert based on source significance and keyword relevance.

High-priority alert based on source significance and keyword relevance.
High-priority alert based on source significance and keyword relevance. — impact context not separately stored; see What changed.
Sources